Prospective Multicenter Study of Chemotherapy-Induced Clostridium (Clostridioides) difficile Infection in Patients With Lung Cancer: North Japan Lung Cancer Study Group Trial 1204
Yukihiro Toi(Sendai Kousei Hospital), Shunichi Sugawara(Sendai Kousei Hospital), Taku Nakagawa(Saint John's Health Center), Tomoya Kuda(Sendai Kousei Hospital), Yoshiaki Mori(Iwate Prefectural Central Hospital), Toshiyuki Harada(Hokkaido hospital), Takao Kobayashi(Hamamatsu Medical Center)
Cited by 7
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
|New England Journal of Medicine|2023|695